Company Filing History:
Years Active: 2002
Title: Innovations of Mustafa Demirbüker
Introduction
Mustafa Demirbüker is a notable inventor based in Järfälla, Sweden. He has made significant contributions to the field of pharmacology through his innovative patents. With a total of 2 patents, his work focuses on the crystallization processes that enhance the delivery of pharmacologically active substances.
Latest Patents
Demirbüker's latest patents include a process for crystallization of amorphous and/or meta-stable crystalline regions of preformed particles. This invention involves treating the particles with a supercritical or subcritical fluid containing an anti-solvent and a solvent. The formulations produced can be used in the treatment of allergic and inflammatory conditions of the nose or lungs. Another patent details a process for preparing essentially crystalline particles containing a substance in solvated form. This process utilizes a first solvent and introduces a supercritical or subcritical fluid, which contains an anti-solvent and water. These formulations also aim to treat similar medical conditions.
Career Highlights
Mustafa Demirbüker is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on developing innovative solutions for health challenges, particularly in the area of respiratory conditions.
Collaborations
Demirbüker has collaborated with notable colleagues such as Mikael Bisrat and Saeed Moshashaee. Their combined expertise contributes to the advancement of pharmaceutical innovations.
Conclusion
Mustafa Demirbüker's contributions to the field of pharmacology through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to influence the development of effective treatments for various medical conditions.